HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of lentigo maligna and lentigo maligna melanoma.

Abstract
The results of treatment of 42 cases of lentigo maligna and 16 of lentigo maligna melanoma at the New York University Medical Center was reviewed. The recurrence rate after surgical excision of 22 lesions of lentigo maligna was 9% (2/22), but after treatment of 20 such lesions with destructive techniques (X rays, curettage-electrodesiccation, cryosurgery), it was 35% (7/20). Of 11 cases of lentigo maligna melanoma that were excised, none recurred locally, but fatal metastases ensued in one case. Five patients who were eventually classified as having lentigo maligna melanomas had been treated by destructive techniques. In four of them there were local recurrences and in two, metastases as well; the fifth patient had metastases without local recurrence. On the basis of this review of these 58 cases, we conclude that surgical excision and careful histologic study of step sections through the entire lesion insure accurate diagnosis and provide the highest cure rates for lentigo maligna and lentigo maligna melanoma.
AuthorsG H Pitman, A W Kopf, R S Bart, P R Casson
JournalThe Journal of dermatologic surgery and oncology (J Dermatol Surg Oncol) Vol. 5 Issue 9 Pg. 727-37 (Sep 1979) ISSN: 0148-0812 [Print] United States
PMID489814 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Aged
  • Cryosurgery
  • Female
  • Humans
  • Lentigo (surgery, therapy)
  • Male
  • Melanoma (surgery, therapy)
  • Middle Aged
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local
  • Retrospective Studies
  • Skin Neoplasms (surgery, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: